Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500105433Phase 3Recruiting
Phase 3, randomised, double-blind trial of ketoprofen in knee osteoarthritis (OA) (3 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Change from baseline in WOMAC pain subscale item 1 (walking on flat surfaces) VAS score at week 4 for target knee. Started Jul 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500105433.